Adam Waldman
Corporate Officer/Principal bei TG THERAPEUTICS, INC.
Aktive Positionen von Adam Waldman
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TG THERAPEUTICS, INC. | Corporate Officer/Principal | 04.06.2018 | - |
Karriereverlauf von Adam Waldman
Ehemalige bekannte Positionen von Adam Waldman
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CELGENE | Corporate Officer/Principal | - | - |
Ausbildung von Adam Waldman
| University of Rochester Simon Business School | Masters Business Admin |
| Rutgers State University of New Jersey | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| Frankreich | 2 |
Operativ
| Corporate Officer/Principal | 2 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TG THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Börse
- Insiders
- Adam Waldman
- Erfahrung